Biolife Solutions (BLFS) EBIT (2016 - 2025)
Historic EBIT for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$89000.0.
- Biolife Solutions' EBIT rose 7870.81% to -$89000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.1 million, marking a year-over-year decrease of 41963.03%. This contributed to the annual value of -$7.1 million for FY2024, which is 6958.62% up from last year.
- According to the latest figures from Q3 2025, Biolife Solutions' EBIT is -$89000.0, which was up 7870.81% from -$16.6 million recorded in Q2 2025.
- Biolife Solutions' EBIT's 5-year high stood at $90.3 million during Q4 2022, with a 5-year trough of -$76.6 million in Q2 2022.
- For the 5-year period, Biolife Solutions' EBIT averaged around -$5.0 million, with its median value being -$4.6 million (2021).
- Per our database at Business Quant, Biolife Solutions' EBIT plummeted by 1045227.27% in 2021 and then soared by 58928.78% in 2022.
- Biolife Solutions' EBIT (Quarter) stood at -$18.5 million in 2021, then skyrocketed by 589.29% to $90.3 million in 2022, then plummeted by 87.5% to $11.3 million in 2023, then tumbled by 118.68% to -$2.1 million in 2024, then surged by 95.78% to -$89000.0 in 2025.
- Its last three reported values are -$89000.0 in Q3 2025, -$16.6 million for Q2 2025, and -$1.2 million during Q1 2025.